| ★ | The Only FDA-Approved Peanut OIT Is Discontinued. Now What? | | 99 | Estados Unidos | |
| 16 | Inside the VESPER-3 Results: Berobenatide's Weight Loss Potential | | 839 | Estados Unidos | 58 |
| 2 | Diabetes Technology at a Turning Point: What’s New and What’s Next | | 581 | Estados Unidos | 63 |
| 11 | Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B | | 521 | Estados Unidos | 58 |
| 8 | Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026 | | 301 | Estados Unidos | 59 |
| 20 | Why Fewer Than Half of Referred Patients Reach Kidney Transplant Evaluation | | 217 | Estados Unidos | 56 |
| 6 | What Comes Next for PORT-77 as It Heads Toward Phase 2b/3? | | 196 | Estados Unidos | 60 |
| 13 | Total Plaque Volume Indicates Patients With 0 CAC May Still be at Risk | | 120 | Estados Unidos | 58 |
| 15 | Preparing Families for the Exa-cel Gene Therapy Journey, With Haydar Frangoul, MD, MS | | 109 | Estados Unidos | 58 |
| 4 | What Does New Phase 3 Amlitelimab Data Suggest for Atopic Dermatitis? | | 92 | Estados Unidos | 61 |
| 12 | What Is Next for OX40 Ligand Inhibition in Atopic Dermatitis? | | 91 | Estados Unidos | 58 |
| 5 | After Sickle Cell Gene Therapy, What Comes Next? | | 78 | Estados Unidos | 60 |
| 7 | Investigational Rapid-Acting U500 Insulin Maintains Efficacy Regardless of BMI | | 61 | Estados Unidos | 59 |
| 14 | ATS 2026 Pulmonology: AD109, Ralinepag, ALIS, Itepekimab & More | HCPLive Expert Interviews | | 55 | Estados Unidos | 58 |
| 17 | Inside the Peanut Allergy Microneedle Stamp Trial, With Brain Vickery, MD | | 39 | Estados Unidos | 57 |
| 9 | POCUS is Standard of Care in Critical Care, With Rhea Votipka, NP | | 35 | Estados Unidos | 59 |
| 1 | Palforzia Is Gone. What Happens to Peanut OIT Now? | | 32 | Estados Unidos | 71 |
| 19 | Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026 | | 31 | Estados Unidos | 56 |
| 3 | Early Introduction & Rescue Refeeding: Rethinking Pediatric Food Allergy | Marcus Shaker, MD | | 17 | Estados Unidos | 62 |
| 10 | The Cost of Delay: How Prior Authorization Is Impacting Dermatology | | 12 | Estados Unidos | 59 |
| 18 | Diabetes Increases Mortality Risk Across All Major Organ Transplants | | 12 | Estados Unidos | 56 |